These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 17260164)

  • 21. Stroke prevention in patients with acute ischemic stroke and atrial fibrillation in Germany - a cross sectional survey.
    Wutzler A; Krogias C; Grau A; Veltkamp R; Heuschmann PU; Haeusler KG
    BMC Neurol; 2019 Feb; 19(1):25. PubMed ID: 30755168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of the Quality of Chronic Anticoagulation Control With Time in Therapeutic Range in Atrial Fibrillation Patients Treated With Vitamin K Antagonists by Hemostasis Specialists: The TERRA Registry: Tiempo en rango en la República Argentina.
    Tajer C; Ceresetto J; Bottaro FJ; Martí A; Casey M;
    Clin Appl Thromb Hemost; 2017 Jul; 23(5):445-453. PubMed ID: 26739542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry.
    Haas S; Ten Cate H; Accetta G; Angchaisuksiri P; Bassand JP; Camm AJ; Corbalan R; Darius H; Fitzmaurice DA; Goldhaber SZ; Goto S; Jacobson B; Kayani G; Mantovani LG; Misselwitz F; Pieper K; Schellong SM; Stepinska J; Turpie AG; van Eickels M; Kakkar AK;
    PLoS One; 2016; 11(10):e0164076. PubMed ID: 27792741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Guidelines for stroke prevention in patients with atrial fibrillation.
    Howard PA
    Drugs; 1999 Dec; 58(6):997-1009. PubMed ID: 10651387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitamin K antagonists for stroke prevention in hemodialysis patients with atrial fibrillation: A systematic review and meta-analysis.
    Van Der Meersch H; De Bacquer D; De Vriese AS
    Am Heart J; 2017 Feb; 184():37-46. PubMed ID: 27892885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The importance of time in therapeutic range in switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulants in atrial fibrillation.
    Vinding NE; Bonde AN; Rørth R; Lamberts M; Olesen JB; Gislason GH; Torp-Pedersen C; Køber L; Fosbøl EL
    Europace; 2019 Apr; 21(4):572-580. PubMed ID: 30508073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of Adherence to Guideline-Directed Antithrombotic Therapy for Atrial Fibrillation at Hospital Discharge.
    Dupree L; DeLosSantos M; Smotherman C
    J Cardiovasc Pharmacol Ther; 2018 Nov; 23(6):502-508. PubMed ID: 29806486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Frequency of use of oral vitamin K antagonists in patients with atrial fibrillation and cognitive function disturbances].
    Gorzelak P; Zyzak S; Krewko Ł; Mozdzan M; Broncel M
    Pol Merkur Lekarski; 2014 May; 36(215):302-6. PubMed ID: 24964505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The cost effectiveness of anticoagulation management services for patients with atrial fibrillation and at high risk of stroke in the US.
    Sullivan PW; Arant TW; Ellis SL; Ulrich H
    Pharmacoeconomics; 2006; 24(10):1021-33. PubMed ID: 17002484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics of patients initiated on edoxaban in Europe: baseline data from edoxaban treatment in routine clinical practice for patients with atrial fibrillation (AF) in Europe (ETNA-AF-Europe).
    De Caterina R; Kelly P; Monteiro P; Deharo JC; de Asmundis C; López-de-Sá E; Weiss TW; Waltenberger J; Steffel J; de Groot JR; Levy P; Bakhai A; Zierhut W; Laeis P; Kerschnitzki M; Reimitz PE; Kirchhof P;
    BMC Cardiovasc Disord; 2019 Jul; 19(1):165. PubMed ID: 31299906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A consultant-led anticoagulation review of all patients in one clinical commissioning group to prevent atrial fibrillation related stroke.
    Grayson AD; Garnett F; Davies M; Connor N; Hughes C; Cooper JP
    Int J Clin Pract; 2020 Apr; 74(4):e13465. PubMed ID: 31854038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atrial fibrillation and medication treatment among centenarians: Are all very old patients treated the same?
    Kreutz R; Schmidt IM; Dräger D; Brüggen F; Hörter S; Zwillich C; Kuhlmey A; Gellert P
    Geriatr Gerontol Int; 2018 Dec; 18(12):1634-1640. PubMed ID: 30259631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Flaws in Anticoagulation Strategies in Patients With Atrial Fibrillation at Hospital Discharge.
    Kartas A; Samaras A; Vasdeki D; Dividis G; Fotos G; Paschou E; Forozidou E; Tsoukra P; Kotsi E; Goulas I; Efthimiadis G; Karvounis H; Tzikas A; Giannakoulas G
    J Cardiovasc Pharmacol Ther; 2019 May; 24(3):225-232. PubMed ID: 30599759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High frequency of anticoagulation management errors preceding ischaemic strokes in atrial fibrillation.
    Wong E; Aaqib M; Thijs V
    Intern Med J; 2022 Jun; 52(6):1024-1028. PubMed ID: 33346950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and quality of warfarin use for patients with atrial fibrillation in the long-term care setting.
    McCormick D; Gurwitz JH; Goldberg RJ; Becker R; Tate JP; Elwell A; Radford MJ
    Arch Intern Med; 2001 Nov; 161(20):2458-63. PubMed ID: 11700158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variables affecting the quality of anticoagulation in atrial fibrillation patients newly initiating vitamin K antagonists: insights from the national and multicentre SULTAN registry.
    Rivera-Caravaca JM; Badimón L; Ferreira-Gonzalez I; Gómez-Doblas JJ; Roca-Luque I; Lekuona I; Jiménez-Candil J; Rodríguez-Padial L; González-Juanatey C; Calvo-Jambrina R; Fácila L; Ruiz-Ortiz M; Anguita M; Marín F
    Europace; 2022 Jan; 24(1):4-11. PubMed ID: 34115857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Patients' characteristics and clinical management of atrial fibrillation in primary healthcare in Spain: FIATE Study].
    Lobos-Bejarano JM; del Castillo-Rodríguez JC; Mena-González A; Alemán-Sánchez JJ; Cabrera de León A; Barón-Esquivias G; Pastor-Fuentes A;
    Med Clin (Barc); 2013 Oct; 141(7):279-86. PubMed ID: 23683967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quality control of oral anticoagulation with vitamin K antagonists in primary care patients in Poland: a multi-centre study.
    Sawicka-Powierza J; Buczkowski K; Chlabicz S; Gugnowski Z; Powierza K; Ołtarzewska AM
    Kardiol Pol; 2018; 76(4):764-769. PubMed ID: 29313558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The SAMe-TT2R2 Score Predicts Poor Anticoagulation Control in AF Patients: A Prospective 'Real-world' Inception Cohort Study.
    Roldán V; Cancio S; Gálvez J; Valdés M; Vicente V; Marín F; Lip GY
    Am J Med; 2015 Nov; 128(11):1237-43. PubMed ID: 26087049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hospitalized frail elderly patients - atrial fibrillation, anticoagulation and 12 months' outcomes.
    Ekerstad N; Karlsson T; Söderqvist S; Karlson BW
    Clin Interv Aging; 2018; 13():749-756. PubMed ID: 29731616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.